Strategic and Industry Partnerships

Oxford AHSN Strategic and Industry Partnerships / Innovation Pathway / Adoption Questions

Adoption pathway

Adoption

The stage of getting your product through NHS procurement and into clinical use. Business cases and clinical evidence will need to be presented to the relevant decision makers.

Questions

adoption-buttons

Filter by product category

Will your diagnostic significantly change the patient pathway or does it require a large investment?

Relevance:Devices and Diagnostics

Have you clarified the value proposition and is it relevant to all stakeholders?

Relevance:PharmaceuticalDevices and DiagnosticsDigital

Can you share, develop or refine a clear business case that can demonstrate to commissioners the clinical and health economic benefits to the local health economy?

Relevance:PharmaceuticalDevices and DiagnosticsDigital

Have you considered engaging with patients and clinical champions to disseminate information?

Relevance:PharmaceuticalDevices and DiagnosticsDigital

Do you understand the procurement route?

Relevance:PharmaceuticalDevices and DiagnosticsDigital

Do you need to revisit your clinical evidence development?

Relevance:Devices and DiagnosticsDigital

Have you engaged all stakeholders both clinical and financial?

Relevance:PharmaceuticalDevices and DiagnosticsDigital

Post-adoption, are you planning to monitor the impact of change to further develop the business case?

Relevance:PharmaceuticalDevices and DiagnosticsDigital

Have you registered the company on UK PharmaScan (if not already registered) and have you ensured relevant data is collected for the registered drug?

Relevance:Pharmaceutical

Have you added drug information and update in a timely manner?

Relevance:Pharmaceutical

If you are producing a vaccine: have you ensured it is entered onto relevant horizon scanning databases and held early dialogue with both regulators and JCVI where possible to ensure vaccine development and evidence generation (including post-authorisation data) will meet approval requirements and support cost-effectiveness?

Relevance:Pharmaceutical

Have you determined whether your product should be considered under Specialised Services for a target patient population? If so, have you engaged with the relevant Clinical Reference Group for advice and put the product forward for assessment? Are you aligned with the strategy for the relevant National Programme of Care? Have you ensured appropriate information and data is published in peer-review journals in order for evidence to be considered? Have you registered as a Clinical Reference Group stakeholder? Have you considered whether a parallel route to reimbursement is required for other target patient populations?

Relevance:Pharmaceutical

Have you considered entering the NIB Workstream 1.2 process?

Relevance:Digital

Have you ensured you have sufficient clinical and economic effectiveness data – NICE are developing a guide to evidence collection for digital health technologies

Relevance:Digital

Have you considered how your product will fit into the current system?

Relevance:PharmaceuticalDevices and DiagnosticsDigital
Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image
Menu